IONIC NANOMEDICINE STRATEGY TO DEVELOP EFFECTIVE CHEMO-PTT COMBINATION CANCER THERAPEUTICS.

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Oncology

Background:

• Chemotherapy (chemo) efficacy is often limited by drug resistance and systemic toxicity.
• Photothermal therapy (PTT) offers a localized treatment modality, but its standalone effectiveness can be insufficient.
• Combining chemo and PTT presents a synergistic approach to enhance anti-cancer treatment outcomes.

Purpose of the Study:

• To develop novel carrier-free ionic nanomaterials (INMs) integrating chemotherapy (tamoxifen and N-desmethyltamoxifen) with a photothermal agent (NaIR820).
• To investigate the photophysical properties and photothermal conversion efficiency of the developed chemo-PTT INMs.
• To evaluate the in vitro efficacy and cytotoxicity of the chemo-PTT INMs compared to individual treatments.

Main Methods:

• Synthesis of ionic materials (IMs) and ionic nanomaterials (INMs) via metathesis and reprecipitation methods.
• Characterization of INMs, including photophysical property analysis (absorption, fluorescence).
• In vitro assessment of dark and light cytotoxicity and apoptosis induction in cancer cells.

Main Results:

• Developed chemo-PTT INMs demonstrated altered absorption and fluorescence spectra compared to the parent NaIR820.
• INMs exhibited enhanced photothermal conversion efficiency and reactive oxygen quantum yield.
• In vitro studies showed superior dark and light cytotoxicity and increased apoptotic cell death for INMs versus chemo or PTT drugs alone.

Conclusions:

• The developed chemo-PTT INMs represent a promising strategy for synergistic cancer therapy.
• These carrier-free nanoparticles effectively combine chemotherapy and photothermal therapy, enhancing drug efficacy and targeted cell killing.
• The enhanced photophysical properties and in vitro results support the potential of INMs for advanced cancer treatment modalities.